Harrow CCO reports 30,000 stock options

Harrow, Inc. filed a Form 3 for Chief Commercial Officer Patrick William Sullivan, reporting a stock option over 30,000 shares of common stock.

Rhea-AI Filing Summary

Harrow, Inc. filed a Form 3 for Chief Commercial Officer Patrick William Sullivan, reporting a stock option over 30,000 shares of common stock. The option has an exercise price of $39 per share and expires on September 1, 2035.

According to the vesting schedule, 25% of the option shares vest on the one-year anniversary of the grant date. The remaining shares vest in 12 equal quarterly installments over the following three years, becoming fully vested and exercisable on September 1, 2029. The option is held directly.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider Sullivan Patrick William

Role CHIEF COMMERCIAL OFFICER

Type	Security	Shares	Price	Value
holding	Stock Option (Right to Buy)	--	--	--

Holdings After Transaction: Stock Option (Right to Buy) — 30,000 contracts (Direct)

Footnotes (1)

1. F1. The shares subject to the option shall vest according to the following schedule: 25% of the shares shall vest at the one-year anniversary of the date of grant, and the remaining shares shall vest over the next three years in 12 equal quarterly installments until fully vested and exercisable on September 1, 2029.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does the Harrow (HROW) Form 3 filing disclose about Patrick Sullivan?

The Form 3 shows that Harrow’s Chief Commercial Officer, Patrick William Sullivan, beneficially owns a stock option over 30,000 shares. The option is held directly, has a $39 exercise price, and provides potential future equity exposure to Harrow’s common stock.

How many Harrow (HROW) shares are covered by Patrick Sullivan’s stock option?

Patrick Sullivan’s reported stock option covers 30,000 shares of Harrow common stock. This option position is disclosed as directly owned and represents his beneficial interest reported as of the Form 3 event date of January 30, 2026, under Section 16 reporting rules.

What is the exercise price and expiration date of Patrick Sullivan’s Harrow (HROW) option?

The stock option has a $39 exercise price and expires on September 1, 2035. These terms define the price at which shares can be purchased and the final date by which the option must be exercised, if vested, before it terminates.

How does the vesting schedule work for Patrick Sullivan’s Harrow (HROW) stock option?

The option vests 25% on the first anniversary of the grant date, then quarterly thereafter. The remaining 75% vests in 12 equal quarterly installments over the next three years, so the option is fully vested and exercisable on September 1, 2029.

Is Patrick Sullivan’s Harrow (HROW) stock option owned directly or indirectly?

The Form 3 reports Patrick Sullivan’s stock option as directly owned, indicated with an ownership code of “D.” No indirect ownership entity or special nature of indirect beneficial ownership is described, so the filing attributes the option directly to him.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Understanding Insider Trading Forms →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 02/02/2026 - 08:20 AM Learn about SEC filing dates

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

Sullivan Patrick William

(Last) (First) (Middle)

C/O HARROW, INC.

1A BURTON HILLS SUITE 200

(Street)

NASHVILLE TN 37215

(City) (State) (Zip)

2. Date of Event Requiring Statement (Month/Day/Year)
01/30/2026

3. Issuer Name and Ticker or Trading Symbol
HARROW, INC. [ HROW ]

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	CHIEF COMMERCIAL OFFICER

5. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Option (Right to Buy)(1)	(1)	09/01/2035	Common Stock	30,000	$39	D

Explanation of Responses:

1. The shares subject to the option shall vest according to the following schedule: 25% of the shares shall vest at the one-year anniversary of the date of grant, and the remaining shares shall vest over the next three years in 12 equal quarterly installments until fully vested and exercisable on September 1, 2029.

Remarks:

Exhibit 24 - POWER OF ATTORNEY

	/s/ Andrew R. Boll as Attorney in Fact for Patrick Sullivan	02/02/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.